1Maron BJ, Olivotto I, Spirito P (2000) Epidemiology
of hypertrophic cardiomyopathy related death: revisited
in a large non-referral-based patient population. Circulation
102:858-864.
2Cavalcante JL, Barboza JS, Lever HM (2012) Diversity
of mitral valve abnormalities in obstructive hypertrophic
cardiomyopathy. Prog Cardiovasc Dis 54:517-522.
3Shone JD, Sellers RD, Anderson RC, et al. (1963)
The developmental complex of “parachute mitral valve,” supravalvular
ring of left atrium, subaortic stenosis, and coarctation
of aorta. Am J Cardiol 11:714-725.
4Bolling SF, Iannettoni MD, Dick M 2nd, et al. (1990)
Shone’s anomaly: operative results and late outcome. Ann
Thorac Surg 49:887-893.
5Nishimura RA, Holmes DR (2004) Hypertrophic
obstructive cardiomyopathy. N Engl J Med 350:1320-1327.
6Yavuzgil O, Tülüce K, Şimşek E, et al. (2012) Septal
alcohol ablation in hypertrophic obstructive cardiomyopathy:
A retrospective review. Turk Gogus Heart Checkers
20:427-433.
7Ünal EU, Özen A, İşcan HZ, et al. (2012). Turk
GogusKalpDama, 20: 421-426
8Mataracı İ, Polat A, Songur ÇM, et al. (2009) Hypertrophic
obstructive cardiomyopathy. Turk GogusKalpDama
17: 243-248.